Posterior Vitreous Detachment (PVD) Assessment During Dual Retinal Vein Occlusion (RVO) Lucentis Evaluations

Inclusion Criteria: * Ability to provide written informed consent and comply with study assessments for the full duration of the study * Subjects of either gender, Age \> 18 years * Best corrected visual acuity in the study eye between 20/40 and 2/200 inclusive. * Retinal venous occlusive disease (BRVO or CRVO) * Clear ocular media and adequate papillary dilation to permit good quality stereoscopic fundus photography, scheimpflug photography and high resolution OCT * Ability to return for all study visits Exclusion Criteria: * Pregnancy (positive pregnancy test) or lactation. * Premenopausal women not using adequate contraception. The following are considered effective means of contraception: surgical sterilization or use of oral contraceptives, barrier contraception with either a condom or diaphragm in conjunction with spermicidal gel, an IUD, or contraceptive hormone implant or patch. * Prior RVO in the study eye * Duration of RVO greater than 6 months * Laser photocoagulation for macular edema within 3 months of Day 0 * Patients prior eye treatment including anti-VEGF therapy (within 3 months) or, intravitreal corticosteroid therapy (within 6 months) * Prior vitreoretinal surgery. * Had ocular surgery within the past 60 days in the study eye. * Concurrent use of more than two therapies for glaucoma. * Uncontrolled glaucoma in the study eye (defined as intraocular pressure \>30 mm Hg despite treatment with anti-glaucoma medication). * Neovascular glaucoma * Concurrent us…